(Q42829698)

8 November 2017

title

Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins (English)

1 reference

8 November 2017

1 reference

Olsen RJ

1

1 reference

8 November 2017

Hinrichs SH

series ordinal

2

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

8 November 2017

1 reference

8 November 2017

volume

20

1 reference

8 November 2017

issue

14

1 reference

8 November 2017

page(s)

1756-1764

1 reference

DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Inhibition of activating transcription factor 1- and cAMP-responsive element-binding protein-activated transcription by an intracellular single chain Fv fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

The regulation of transcription by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Phosphorylation of B-Myb regulates its transactivation potential and DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

The role of Ets transcription factors in the development and function of the mammalian immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

Cytogenetics and experimental models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

Protein kinase C: a worthwhile target for anticancer drugs?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204268

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204268

1 reference

Dimensions Publication ID

8 November 2017

1019375730

0 references

1 reference